Similar Articles |
|
BusinessWeek December 5, 2005 Bettina Wassener |
The Strong Hand Of A Shy Billionairess A Quandt dynasty heiress looks to split up German drug company Altana and find some value for investors. |
The Motley Fool October 23, 2006 Brian Lawler |
No Slowing Novartis The Swiss pharmaceutical company shows strength in nearly all its divisions. Novartis looks like a good investment for risk-adverse investors searching for a large-cap pharma stock. |
Chemistry World January 11, 2010 Sean Milmo |
Evonik refocuses German chemicals, energy and real estate conglomerate Evonik Industries, is refocusing its operations on its chemical business in order to become a more powerful global player in the speciality chemicals arena. |
Chemistry World May 20, 2011 Sarah Houlton |
Takeda expands into Europe with Nycomed deal Japanese pharma company Takeda is to acquire Swiss-headquartered rival Nycomed for 9.6 billion. If the antitrust authorities give the go-ahead, the takeover should be completed by late summer. |
The Motley Fool February 22, 2005 Rich Duprey |
Merger Mania Besets Japanese Pharmaceuticals A new law spurs megamergers in Japan's pharmaceutical industry. Stocks of companies seen as particularly interesting, including Eisai, Mitsubishi Pharma, and Shionogi, all jumped more than 2%. |
Chemistry World January 3, 2013 Andrew Turley |
Clariant sells business bundle for CHF500m Speciality chemical firm Clariant has struck a deal to sell its textile, paper and emulsion products businesses for 500 million Swiss francs. |
The Motley Fool October 22, 2007 Brian Lawler |
No Catastrophes at Novartis Novartis stays on track with its third-quarter results. Investors, take note. |
Chemistry World January 20, 2012 Sarah Houlton |
Takeda slashes 10% of its workforce This represents about 10% of its workforce, and the cuts will be made in research, commercial and admin sections of the business. |
Chemistry World June 27, 2012 Laura Howes |
Clariant to sell businesses Swiss speciality chemicals company Clariant has released its strategic targets up until 2015. |
Chemistry World December 15, 2008 Sean Milmo |
What's in store for the chemicals industry? Sizing up their prospects at the beginning of 2008, chemical companies knew economists were warning of an imminent recession. But the swiftness of the year's global downturn took many by surprise. |
Chemistry World December 19, 2011 Rebecca Trager |
US agencies collaborate to test 10,000 chemicals A high-speed robotic screening system jointly initiated by three key US health agencies began testing more than 10,000 chemical compounds for potential toxicity on 7 December. |
The Motley Fool February 27, 2006 Rich Smith |
1,001 Teutonic Nights, Part 4 Investors, get to know Germany: Fresenius Medical Care... Altana... Schering... |
Chemistry World December 21, 2011 Sean Milmo |
Early optimism fades with EU crisis By the end of the year, chemical producers were facing the dilemma of how to deal with the effects of possible economic turmoil. |
Pharmaceutical Executive March 1, 2006 Sarah Houlton |
Global Report: Chemicals Legislation in Europe Chemicals legislation in Europe may affect pharma's relationship with suppliers. |
Chemistry World July 26, 2012 Andrew Turley |
New US chemical rules edge nearer A political committee in the US has voted in favor of plans to change the way chemicals are regulated by shifting the burden of proving safety to manufacturers. |
The Motley Fool November 12, 2009 Brian Orelli |
How Do You Say 'Drug Development' in Mandarin? Drug giant Novartis announces that it's heading to China in a big way. |
Information Today June 20, 2011 |
EPA Releases Two New Databases With Chemical Toxicity and Exposure Data The U.S. Environmental Protection Agency has announced the release of two databases that make it easier to find data about chemicals. |
Chemistry World December 23, 2009 Sean Milmo |
2009 marks the start of the great divide The recession is opening up a big gap in output performance between the chemical industries of the developed and developing worlds, which will continue to widen over the next few years. |
The Motley Fool May 22, 2008 Brian Orelli |
Wyeth's Never-Ending Generic Woes Novartis jumps on the generic Protonix bandwagon. |
Chemistry World October 1, 2008 Rebecca Trager |
US to Overhaul Industrial Chemicals Inventory A plan by the US Environmental Protection Agency to overhaul its inventory of industrial chemicals could lead to a lot more paperwork for chemical firms, industry officials have warned. |
Chemistry World June 13, 2008 Hepeng Jia |
Olympic chemical restrictions worries industry The Chinese government's drive to restrict the movement and manufacture of chemicals ahead of the Beijing Olympics could hit the country's chemical industry, analysts have warned. |
Chemistry World July 23, 2014 Phillip Broadwith |
Albemarle buys into lithium with Rockwood merger US specialty chemicals firms Albemarle and Rockwood have agreed to merge in a deal worth around $6.2 billion. |
Chemistry World September 18, 2012 James Urquhart |
UN report urges chemical industry to clean-up Governments and industry worldwide must address the management of chemicals in order to curtail the escalating heath and environmental risks associated with the widespread production, use and disposal of chemicals, warns the United Nations Environment Program. |
The Motley Fool November 30, 2006 Brian Lawler |
Durect's Pain-Free Deal A partnership deal has investors in the small specialty pharma excited. |
The Motley Fool July 6, 2007 Brian Lawler |
Medicines Decides Not to Share The Medicines Company reacquires its own drug. Until now, privately held European specialty pharma Nycomed has marketed Angiomax in Europe. Investors, take note. |